US Stock MarketDetailed Quotes
RANI Rani Therapeutics
- 6.680
- +0.120+1.83%
Close Apr 26 16:00 ET
- 6.870
- +0.190+2.84%
Post 19:57 ET
175.67MMarket Cap-5022P/E (TTM)
6.700High6.295Low42.50KVolume6.480Open6.560Pre Close277.36KTurnover0.32%Turnover RatioLossP/E (Static)26.30MShares8.75052wk High13.66P/B89.79MFloat Cap1.82052wk Low--Dividend TTM13.44MShs Float36.270Historical High--Div YieldTTM6.18%Amplitude1.820Historical Low6.526Avg Price1Lot Size
Rani Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -10.15%-51.24M | 14.70%-12.48M | -17.26%-14.3M | -19.10%-12.3M | -29.85%-12.15M | -44.25%-46.52M | -27.78%-14.63M | -9.69%-12.2M | -83.51%-10.33M | -131.23%-9.36M |
| Net income from continuing operations | -7.17%-67.88M | 18.95%-14.06M | -13.10%-18.33M | -16.90%-18.66M | -21.72%-16.83M | -19.32%-63.34M | -30.34%-17.34M | 43.53%-16.21M | -191.08%-15.97M | -147.02%-13.83M |
| Depreciation and amortization | 50.00%822K | 30.46%227K | 54.61%218K | 54.92%189K | 69.37%188K | 10.26%548K | 53.98%174K | 17.50%141K | -4.69%122K | -18.38%111K |
| Other non cash items | 51.37%1.27M | 8.50%319K | 38.26%318K | 98.75%318K | 102.55%318K | 671.56%841K | 29,300.00%294K | 1,537.50%230K | 180.70%160K | 134.33%157K |
| Change In working capital | -520.43%-2.14M | -85.37%-2.99M | -56.24%-864K | -8.84%1.26M | -64.79%456K | 114.84%509K | -13.43%-1.61M | 72.42%-553K | 302.94%1.38M | 91.00%1.3M |
| -Change in prepaid assets | -44.16%282K | -44.05%348K | 36.01%-926K | -10.67%544K | -56.17%316K | 125.57%505K | 29.58%622K | 41.11%-1.45M | 2,536.00%609K | 2,570.37%721K |
| -Change in payables and accrued expense | -247.79%-1.14M | -41.62%-2.83M | -70.95%321K | 4.83%976K | -45.42%399K | -39.19%768K | -5.10%-2M | 144.47%1.11M | -28.71%931K | -48.05%731K |
| -Change in other current assets | ---245K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | -36.39%-1.04M | -11.02%-262K | -22.75%-259K | -63.75%-262K | -64.97%-259K | ---764K | ---236K | ---211K | ---160K | ---157K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -10.15%-51.24M | 14.70%-12.48M | -17.26%-14.3M | -19.10%-12.3M | -29.85%-12.15M | -44.25%-46.52M | -27.78%-14.63M | -9.69%-12.2M | -83.51%-10.33M | -131.23%-9.36M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 141.22%29.86M | 3,004.60%13.27M | 116.36%11.67M | 308.18%789K | 1,723.23%4.12M | -14,215.42%-72.44M | -68.63%-457K | -71.35M | -178.68%-379K | -156.57%-254K |
| Net PPE purchase and sale | 24.09%-1.23M | 68.49%-167K | -5.04%-479K | 11.61%-335K | 2.36%-248K | -219.96%-1.62M | -95.57%-530K | ---456K | -178.68%-379K | -156.57%-254K |
| Net investment purchase and sale | 143.90%31.09M | 18,312.33%13.44M | 117.14%12.15M | --1.12M | --4.37M | ---70.82M | --73K | ---70.89M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 141.22%29.86M | 3,004.60%13.27M | 116.36%11.67M | 308.18%789K | 1,723.23%4.12M | -14,215.42%-72.44M | -68.63%-457K | ---71.35M | -178.68%-379K | -156.57%-254K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.20%233K | -99.35%96K | -99.65%49K | 63.27%80K | 8K | -62.40%29.01M | 2,709.47%14.87M | -80.32%14.08M | 103.09%49K | 0 |
| Net issuance payments of debt | --0 | --0 | ---- | ---- | ---- | 1,138.41%29.57M | --14.9M | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 24.61%395K | -21.95%96K | -46.21%78K | 81.63%89K | --132K | 1,119.23%317K | --123K | 1,015.38%145K | --49K | --0 |
| Net other financing activities | 81.72%-162K | --0 | ---29K | ---9K | ---124K | ---886K | ---152K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.20%233K | -99.35%96K | -99.65%49K | 63.27%80K | --8K | -62.40%29.01M | 2,709.47%14.87M | -80.32%14.08M | 103.09%49K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -76.58%27.51M | -80.26%5.47M | -91.71%8.05M | -81.93%19.48M | -76.58%27.51M | 60.77%117.45M | -78.64%27.72M | 40.20%97.18M | 40.67%107.84M | 60.77%117.45M |
| Current changes in cash | 76.49%-21.14M | 520.75%892K | 96.29%-2.58M | -7.26%-11.43M | 16.55%-8.02M | -302.60%-89.95M | 98.28%-212K | -214.95%-69.46M | -45.05%-10.66M | -366.76%-9.61M |
| End cash Position | -76.86%6.36M | -76.86%6.36M | -80.26%5.47M | -91.71%8.05M | -81.93%19.48M | -76.58%27.51M | -76.58%27.51M | -78.64%27.72M | 40.20%97.18M | 40.67%107.84M |
| Free cash flow | -9.00%-52.47M | 16.58%-12.65M | -16.82%-14.78M | -18.02%-12.64M | -29.00%-12.4M | -46.97%-48.13M | -29.34%-15.16M | -13.79%-12.65M | -85.76%-10.71M | -131.83%-9.61M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg